Press Releases

August 14, 2017: ICON-1 Plus Ranibizumab Shows Promise for Wet AMD | MD Magazine.
Read More…

August 22, 2017: Iconic Therapeutics Appoints Brandon Smith Chief Operating Officer
Read More…

April 6, 2017: Iconic Therapeutics Appoints Julia P. Gregory To Board Of Directors
Read More…

February 9, 2017: Iconic Therapeutics To Present Phase 2a EMERGE Trial Results at Miami Meeting

Read More…

August 9, 2016: Iconic Therapeutics Announces Final Close Of Series C Financing With Additional $10 Million Investment.

Read More…

January 11, 2016: Iconic Therapeutics Closes Series C Financing with New and Existing Investors

Read More…

May 12, 2015: K. Peter Hirth, PhD, Joins Iconic Therapeutics as Board Member and Senior Scientific Advisor

Read More…

April 16, 2014: Iconic Therapeutics Raises $20 Million to Advance Clinical Development of Wet AMD Program

Read More…